Firmenbeschreibung
Die SYNLAB-Gruppe ist der größte europäische Anbieter von klinischen Labor- und medizinischen Diagnostikdienstleistungen nach Umsatz und durchgeführten Tests. SYNLAB bietet die gesamte Bandbreite innovativer und zuverlässiger medizinischer Diagnostik für Patienten, niedergelassene Ärzte, Kliniken und die pharmazeutische Industrie an. Aufgrund branchenweit höchster Servicestandards ist SYNLAB der bevorzugte Partner für die Diagnostik in der Human- und Veterinärmedizin. Durch kontinuierliche Innovationen medizinischer Diagnostikdienstleistungen trägt die Gruppe zum Wohl von Patienten und Kunden bei.
KeyData
| endOfFinancialYear: | 31.12.2022 00:00 |
| stockholderStructure: | Cinven (Luxco 1) S.A. (46.13%),Novo Nordisk Foundation (19.55%),Freefloat (14.99%),Ontario Teachers' Pension Plan Board (9.59%),State of Qatar (4.99%),Dr. Bartl Wimmer (4.75%) |
| sharesOutstanding: | 222222000.0000 |
| ceo: | Mathieu Floreani |
| board: | Sami Badarani |
| supervisoryBoard: | Prof. Dr. David Ebsworth, Marc Welters, Anastasya Molodykh- McFarlane, Barbara Lambert, Christian Salling, Dr. Bartl Wimmer, Dr. med. Ute Hasholzner, Dr. Stefan Graf, Iris Schopper, Karin Bierstedt, Peter Catterall, Rene Schmidt-Ferroud |
| countryID: | 2 |
| faceValue: | 1.0000 |
| faceValueCurrencyID: | 1 |
| faceValueCurrency: | EUR |
| sectorName: | Gesundheitsanbieter |
| industryName: | Gesundheitswesen |
| subsectorName: | Gesundheitswesen, Krankenkassen |
| country: | Deutschland |
| countryName: | Deutschland |
Kontakt
| email: | ir@synlab.com |
| irWebSite: | https://ishort.ink/ZbTF |
Adresse
| street: | Moosacher Straße 88 |
| city: | D-80809 München |
| phone: | +49-89-307-602-0 |
| webSite: | https://www.synlab.de/ |
| email: | info@synlab.com |
Finanzen (kurz)
| year: | 2021 | cash: | 443.7000 |
| balanceSheetTotal: | 5425.9000 | liabilities: | 3170.2000 |
| totalShareholdersEquity: | 2255.7000 | sales: | 3764.9000 |
| bankLoans: | 1179.9000 | investment: | 65.8000 |
| incomeBeforeTaxes: | 805.6000 | netIncome: | 624.8000 |
| cashFlow: | -461.2000 | employees: | 30570 |
| currencyID: | 1 | units: | 1000000 |
| currency: | EUR |
Finanzen (kurz)
| year: | 2021 |
| cash: | 443.7000 |
| balanceSheetTotal: | 5425.9000 |
| liabilities: | 3170.2000 |
| totalShareholdersEquity: | 2255.7000 |
| sales: | 3764.9000 |
| bankLoans: | 1179.9000 |
| investment: | 65.8000 |
| incomeBeforeTaxes: | 805.6000 |
| netIncome: | 624.8000 |
| cashFlow: | -461.2000 |
| employees: | 30570 |
| currencyID: | 1 |
| units: | 1000000 |
| currency: | EUR |
Finanzen (ausführlich)
| year: | 2021 | units: | 1000000 |
| balanceSheetTotal: | 5425.9000 | cash: | 443.7000 |
| currentAssets: | 1312.4000 | liabilities: | 955.5000 |
| totalLiabilitiesEquity: | 5425.9000 | provisions: | 315.1000 |
| totalShareholdersEquity: | 2255.7000 | employees: | 30570 |
| property: | 273.0000 | intangibleAssets: | 725.9000 |
| inventories: | 110.0000 | accountsReceivable: | 632.6000 |
| accountsPayable: | 387.1000 | liabilitiesBanks: | 1430.2000 |
| liabilitiesTotal: | 3170.2000 | longTermDebt: | 1417.6000 |
| shortTermDebt: | 12.6000 | minorityInterests: | -1.2000 |
| sales: | 3764.9000 | depreciation: | 265.4000 |
| netIncome: | 624.8000 | operatingResult: | 914.5000 |
| ebitda: | 1179.9000 | incomeInterest: | -102.5000 |
| incomeTaxes: | 195.3000 | materialCosts: | 942.4000 |
| personnelCosts: | 1138.9000 | costGoodsSold: | 2081.3000 |
| grossProfit: | 1683.6000 | minorityInterestsProfit: | -2.8000 |
| revenuePerEmployee: | 123156.6896 | cashFlow: | 1011.7000 |
| cashFlowInvesting: | -381.0000 | cashFlowFinancing: | -1104.1000 |
| cashFlowTotal: | -461.2000 | equityRatio: | 41.5728 |
| debtEquityRatio: | 140.5417 | liquidityI: | 46.4364 |
| liquidityII: | 112.6426 | netMargin: | 16.5954 |
| grossMargin: | 44.7183 | cashFlowMargin: | 26.8719 |
| ebitMargin: | 24.2902 | ebitdaMargin: | 31.3395 |
| preTaxROE: | 35.7140 | preTaxROA: | 14.8473 |
| roe: | 27.6987 | roa: | 11.5151 |
| taxExpenseRate: | 24.2428 | equityTurnover: | 1.6691 |
| epsBasic: | 2.8200 | epsDiluted: | 2.8200 |
| shareCapital: | 222.2220 | incomeBeforeTaxes: | 805.6000 |
| priceEarningsRatioCompany: | 8.3688 | priceCashFlowRatio: | 5.0191 |
| dividendYield: | 1.3983 | bookValuePerShare: | 10.4838 |
| marketCap: | 5077776000.0000 | earningsYield: | 11.9492 |
| cashFlowPerShare: | 4.7021 | netAssetsPerShare: | 10.4782 |
| priceBookValueRatio: | 2.2511 | dividendsPerShare: | 0.3300 |
| priceEarningsRatio: | 8.1270 | netEarningsPerShare: | 2.9039 |
| currency: | EUR |
| year: | 2022 | priceEarningsRatioCompany: | 3.5993 |
| priceCashFlowRatio: | 2.1586 | dividendYield: | 3.2512 |
| bookValuePerShare: | 10.4838 | marketCap: | 2183874000.0000 |
| earningsYield: | 27.7833 | cashFlowPerShare: | 4.7021 |
| priceBookValueRatio: | 0.9682 | priceEarningsRatio: | 3.4953 |
| netEarningsPerShare: | 2.9039 | currency: | EUR |
Finanzen (ausführlich)
| year: | 2021 |
| units: | 1000000 |
| balanceSheetTotal: | 5425.9000 |
| cash: | 443.7000 |
| currentAssets: | 1312.4000 |
| liabilities: | 955.5000 |
| totalLiabilitiesEquity: | 5425.9000 |
| provisions: | 315.1000 |
| totalShareholdersEquity: | 2255.7000 |
| employees: | 30570 |
| property: | 273.0000 |
| intangibleAssets: | 725.9000 |
| inventories: | 110.0000 |
| accountsReceivable: | 632.6000 |
| accountsPayable: | 387.1000 |
| liabilitiesBanks: | 1430.2000 |
| liabilitiesTotal: | 3170.2000 |
| longTermDebt: | 1417.6000 |
| shortTermDebt: | 12.6000 |
| minorityInterests: | -1.2000 |
| sales: | 3764.9000 |
| depreciation: | 265.4000 |
| netIncome: | 624.8000 |
| operatingResult: | 914.5000 |
| ebitda: | 1179.9000 |
| incomeInterest: | -102.5000 |
| incomeTaxes: | 195.3000 |
| materialCosts: | 942.4000 |
| personnelCosts: | 1138.9000 |
| costGoodsSold: | 2081.3000 |
| grossProfit: | 1683.6000 |
| minorityInterestsProfit: | -2.8000 |
| revenuePerEmployee: | 123156.6896 |
| cashFlow: | 1011.7000 |
| cashFlowInvesting: | -381.0000 |
| cashFlowFinancing: | -1104.1000 |
| cashFlowTotal: | -461.2000 |
| equityRatio: | 41.5728 |
| debtEquityRatio: | 140.5417 |
| liquidityI: | 46.4364 |
| liquidityII: | 112.6426 |
| netMargin: | 16.5954 |
| grossMargin: | 44.7183 |
| cashFlowMargin: | 26.8719 |
| ebitMargin: | 24.2902 |
| ebitdaMargin: | 31.3395 |
| preTaxROE: | 35.7140 |
| preTaxROA: | 14.8473 |
| roe: | 27.6987 |
| roa: | 11.5151 |
| taxExpenseRate: | 24.2428 |
| equityTurnover: | 1.6691 |
| epsBasic: | 2.8200 |
| epsDiluted: | 2.8200 |
| shareCapital: | 222.2220 |
| incomeBeforeTaxes: | 805.6000 |
| priceEarningsRatioCompany: | 8.3688 |
| priceCashFlowRatio: | 5.0191 |
| dividendYield: | 1.3983 |
| bookValuePerShare: | 10.4838 |
| marketCap: | 5077776000.0000 |
| earningsYield: | 11.9492 |
| cashFlowPerShare: | 4.7021 |
| netAssetsPerShare: | 10.4782 |
| priceBookValueRatio: | 2.2511 |
| dividendsPerShare: | 0.3300 |
| priceEarningsRatio: | 8.1270 |
| netEarningsPerShare: | 2.9039 |
| currency: | EUR |
| year: | 2022 |
| priceEarningsRatioCompany: | 3.5993 |
| priceCashFlowRatio: | 2.1586 |
| dividendYield: | 3.2512 |
| bookValuePerShare: | 10.4838 |
| marketCap: | 2183874000.0000 |
| earningsYield: | 27.7833 |
| cashFlowPerShare: | 4.7021 |
| priceBookValueRatio: | 0.9682 |
| priceEarningsRatio: | 3.4953 |
| netEarningsPerShare: | 2.9039 |
| currency: | EUR |
